Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2022 Dec 17;12:21847. doi: 10.1038/s41598-022-26274-z

Effect of using 5A’s model for lifestyle counseling on psychological symptoms in women with polycystic ovary syndrome: a randomized field trial

Fatemeh ZareMobini 1, Ziba Farajzadegan 2, Ashraf Kazemi 3,, Mehrdad Salehi 4
PMCID: PMC9759549  PMID: 36528714

Abstract

Lifestyle modification in women with polycystic ovary syndrome (PCOS) could be associated with increased psychological symptoms. This study aimed to evaluate the effect of lifestyle modification counseling using 5A’s model on the psychological symptoms of women with PCOS. This double-blind, randomized field trial was performed on 70 women with PCOS in two groups of lifestyle modification counseling based on 5A’s model and counseling without using the model. The intervention was performed based on five stages of the 5A’s model (Assess, Advise, Agree, Assist, Arrange) during a week, and psychological symptoms were assessed using Symptom Checklist-90-R before the intervention and one and three months after the intervention. The results showed that one and three months after the intervention, the level of psychological symptoms, except obsessive–compulsive level, were significantly lower in the intervention group than in the control group (p < 0.05). Moreover, the level of these symptoms decreased over time in the intervention group (p < 0.0001). Using the 5A’s model in lifestyle modification counseling is associated with the promotion of psychological health in women with PCOS, and this model is recommended for lifestyle counseling in women with polycystic ovary syndrome.

Subject terms: Human behaviour, Psychology

Introduction

Polycystic ovary syndrome (PCOS) is an endocrine disorder in women whose clinical manifestations could be followed by psychological effects such as body image distress1, decreased self-esteem2, sexual dysfunction3, depression, and anxiety4. Additionally, the high risk of infertility, diabetes5, cardiovascular disease6, and breast cancer7 endanger the mental health of patients8.

Given the metabolic nature of this disorder, lifestyle modification has been accepted as the first line of treatment in women with PCOS9,10. Several studies have shown that lifestyle modifications to reduce carbohydrate intake11 along with exercise programs can reduce insulin resistance and androgen level and initiate ovulation12.

Although a lifestyle modification approach is essential in managing PCOS, following dietary and physical activity recommendations require clients' self-confidence13 and self-efficacy14. However, the chronic nature of the disease and its manifestations, such as hirsutism, acne, menstrual disorders, infertility15, and the social problems caused by it16, will reduce patients’ self-confidence17 and self-efficacy. Qualitative studies evaluating affected women’s experiences show that this disorder is considered a debilitating disease18 with an uncertain future for patients19. Nevertheless, obtaining knowledge about the disease is associated with an improved sense of disease control in patients and improves their quality of life and mental health20.

Therefore, it is necessary for individuals to receive lifestyle modification counseling based on psychological conditions and needs. Moreover, counseling programs should have the necessary flexibility. In this regard, it is recommended that treatment programs with a multidisciplinary approach be designed and psychological counseling be included in treatment programs for patients with PCOS10,21.

Several studies have shown the effect of counseling on the lifestyle of women with PCOS22,23. Cognitive-based psychological counseling, such as Cognitive-behavioral therapy, has also resulted in positive outcomes on the mental health of women with PCOS24. However, in order to provide lifestyle counseling services for women with PCOS, an integrated model is required25. Therefore, counseling can be provided by taking into account the specific psychological conditions of PCOS patients and can promote their mental health.

5A’s is a counseling model that focuses on the individual's cognition of the situation and helps the client to design operational plans for cognition-based lifestyle modification they have received from their living conditions.

5A’s is a behavior change model with five steps including assess, advise, agree, assist, and arrange26, and was used in obesity-related counseling for weight loss2628. However, no study has hitherto investigated the effect of lifestyle modification counseling by using this model on clients’ mental health. Accordingly, the present study was conducted to evaluate the effect of a lifestyle modification counseling program based on 5A’s model on the mental health of women with PCOS. Therefore, the aim of the study was to assess the effect of using 5A’s model for lifestyle counseling on psychological symptoms in women with polycystic ovary syndrome.

Materials and methods

This study is the field trial part of a mixed study conducted in a randomized, double-blind way with the approval of the ethics committee of Isfahan University of Medical Sciences, Iran. The study was conducted on 70 women with polycystic ovary syndrome based on Rotterdam criteria29 from August 2019 to January 2020 in Isfahan, Iran. The sample size was calculated for a 1:1 allocation ratio by considering presumed depression score reduction after the intervention, estimated sample attrition, 95% confidence level, and 80% test power with two parallel groups of intervention and control sequentially.

Inclusion criteria included no severe psychological disorders and no movement restrictions. Additionally, women undergoing assisted reproductive treatment were not included in the study. An eligibility assessment was performed by the Ph.D. candidate in reproductive health. Simple random sampling was performed among women referring to the treatment clinics affiliated with Isfahan University of Medical Sciences.

In this study, psychological symptoms were measured on the scales of somatization, interpersonal sensitivity, obsessive–compulsive disorder, depression, anxiety, and hostility using SCL-90-R by one researcher. This checklist was set based on a 5-point Likert scale (0–4) ranging from none (0) to too much (4), and the higher the score, the more psychological symptoms would be30. The participants' psychological symptoms scores were measured in both groups before the intervention and one and three months later.

Two midwives, who were familiarized with the process during a session, contributed to the sampling process. For sampling, the files of all patients referred daily to the Gynecology and Endocrinology Clinic were evaluated. Then, an initial interview was conducted with the women with even file numbers, and the eligible ones were invited to participate in the study. After obtaining informed consent and recording the baseline information, SCL-90-R was completed as a self-report. After completing the questionnaires, the participants were introduced to the second midwife for random allocation to the intervention or control groups using 70 cards marked equally as A or B. Each participant took a card out of the envelope identifying one of the research groups. Unlike the first midwife, the participant and the midwife performing the random assignment were unaware of which group each color belonged to. After determining each group, each participant was referred to the first midwife to receive either an intervention or control program.

Intervention program

An intervention program was developed using 5A’s model in order to provide lifestyle counseling and was performed by one reproductive health specialist. This model included five stages: assess, advise, agree, assist, and arrange, presented individually during four sessions of 45–60 min. With regard to the Assess stage, not only body mass index but also knowledge, beliefs, and lifestyle were assessed in terms of physical activity and nutritional behaviors. In the Advise stage, the disease, the effect of lifestyle on the disease course and symptoms, and behavioral problems of nutrition and physical activity were explained. Computational skills were also explained to balance the received and consumed calories. In the Agree stage, behavioral goals were identified based on each person's interests and priorities, and an agreement was reached with the participant for changing behavior and implementing a practical plan to achieve the goals. These three steps were performed in three sessions.

During the fourth session and regarding the Assist stage, the participant was helped to discuss barriers to the implementation of lifestyle modification practical programs and barrier removal strategies. Moreover, based on the mentioned barriers, each participant was helped to identify the sources of social support related to their problem.

In the Arrange stage, based on the participants' preference, their progress regarding dietary behaviors and physical activity was followed through the telephone call. For the control group, face-to-face nutritional and physical activity recommendations were provided in two sessions with an interval of one week.

Research data were analyzed using SPSS software version 19 and statistical methods of independent t-test, Chi-square, Mann–Whitney, and repeated measure analysis of variance. The significance level in data analysis was lower than 0.05. This field trial was registered at the Iranian Registry of Clinical Trials on 03/10/2017 (IRCT2017092736445N1).

Ethics approval and consent to participate

All procedures performed on participants were in accordance with the ethical standards of the Isfahan University of Medical Sciences, and informed consent was obtained from all participants.

Results

Of the 75 eligible women invited to the study, 70 accepted the invitation. One participant in the control group was excluded from the study because of initiating assisted reproductive treatment during the study. Two participants of each group were excluded from the study because of their unwillingness to participate, and finally, 33 subjects remained in each group (Fig. 1). The baseline characteristics of the participants in the two groups are provided in Table 1. Based on the results, the two groups were not significantly different in terms of baseline characteristics (Table 1).

Figure 1.

Figure 1

Consort diagram.

Table 1.

Comparison of baseline characteristics in study groups.

Intervention Group (n = 33) Control Group (n = 33) Sig
Mean (SD) or Number (%) Mean (SD) or Number (%)
Age (Year) 29.15 (6.94) 30.15 (6.48) ns
Education level (%)
Diploma or less 14 (42.40) 20 (60.7) ns
More than diploma 19 (51.5) 13 (33.3)
Occupational status (%)
Employed 10 (30.3) 9 (27.3) ns
Infertility (%) 7 (21.2) 8 (24.2) ns
Body mass index (kg/m2) 28.15 (5.57) 27.21 (4.02) ns

SD standard deviation; sig significance; ns not significant.

Additionally, the two groups were not significantly different in terms of the measured psychological symptoms before the intervention. There was a significant difference between the mean scores of somatization, interpersonal sensitivity, anxiety, depression, and hostility one and three months after the intervention. The effect of the group on changes in the mean score of somatization, interpersonal sensitivity, anxiety, depression, hostility, and obsessive–compulsive disorders was significant. Accordingly, all psychological symptoms were lower in the intervention group than in the control group one and three months after the intervention (Table 2). According to the results, somatization, interpersonal sensitivity, anxiety, and hostility decreased in the intervention group one and three months after the intervention. The depression likewise decreased after one month; however, its score one month after the intervention was not significantly different from three months after. The level of obsessive–compulsive disorder did not change one and three months after the intervention.

Table 2.

Comparison of psychologic symptoms and self-efficacy scores between two groups by three times.

Mean (SD) Siga Time/group
Int G Con G Fb Sigb Fc Sigc
Somatization
At Intake 1.17 (.68) .80 (.75) ns
After 1 month .55(.53) .81 (.74)  < .0001 255.73  < .0001 173.20  < .0001
After 3 month .28 (.38) 1.67 (.57)  < .0001
Interpersonal sensitivity
At Intake 1.29 (.80) .96 (.68) ns 10.65 .001 184.40
After 1 month .76 (.55) 1.25 (.68) .002  < .0001
After 3 month .38 (.37) 1.54 (.64)  < .0001
Obsessive–compulsive disorder
At Intake 1.07 (.73) .88 (.75) ns 8.57 .002 8.08 .002
After 1 month 1.07 (.74) .99 (.95) ns
After 3 month 1.09 (.72) .95 (.93) ns
Depression
At Intake 1.22 (.76) .91 (.86) ns 30.03 63.85
After 1 month .48 (.28) .85 (.88) .009  < .0001  < .0001
After 3 month .29 (.32) .86 (.58)  < .0001
Anxiety
At Intake 1.05 (.82) .88 (.67) ns 7.20 .005 82.40
After 1 month .47 (.50) 1.10 (.64)  < .0001  < .0001
After 3 month .24 (.21) 1.09 (.50)  < .0001
Hostility
At Intake .92 (.72) .81 (.55) ns 14.67  < .0001 43.36  < .0001
After 1 month .37 (.41) .97 (.58)  < .0001
After 3 month .23 (.31) .98 (.58)  < .0001

a Difference between groups; the results of the t test.

b test of within subject effect.

c test of between subject effect.

SD standard deviation; sig significance; ns not significant.

In the control group, the changes in somatization, interpersonal sensitivity, obsessive–compulsive disorders, and anxiety were significant and upward during the study's three periods. There was no significant difference in the level of depression immediately and one month after the intervention; however, its level increased significantly one month and three months after the intervention. Hostility level also increased in the control group between the first and second measurement times; however, it did not change between one and three months after the intervention (Table 3).

Table 3.

Pairwise comparison of the psychological symptoms in two groups by three times.

(I): Time (J): Time Psychological symptoms
Somatization Interpersonal sensitivity Obsessive–compulsive disorder Depression Anxiety Hostility
(I-J) Sig (I-J) Sig (I-J) Sig (I-J) Sig (I-J) Sig (I-J) Sig
Intervention group
At intake After 1 month .62  < .0001 .53  < .0001 .000 ns .74  < .0001 .58  < .0001 .55  < .0001
After 3 month .89  < .0001 .91  < .0001  − .003 ns .93  < .0001 .81  < .0001 .55  < .0001
After 1 month After 3 month .27  < .0001 .38  < .0001 .000 ns .19 .002 .24  < .0001 .14  < .0001
Control group
At intake After 1 month  − .01 ns  − .29  < .0001  − .11 .002 .06 ns  − .22 .03  − .16 .003
After 3 month  − .87  < .0001  − .58  < .0001  − .07 ns .05 ns  − .21 .04  − .17  < .0001
After 1 month After 3 month  − .86  < .0001  − .29  < .0001  − .04 ns  − .01 ns .01 ns  − .01 ns

(I-J) Mean Difference; sig significance; ns not significant.

Discussion

The aim of this study was to evaluate the effect of lifestyle modification counseling using 5A’s model on the psychological symptoms of women with PCOS. The results showed that using this model for lifestyle modification counseling could reduce psychological symptoms in these women.

Findings showed that in the intervention group, the levels of somatization, interpersonal sensitivity, anxiety, depression, and hostility symptoms were decreased and were lower than in the control group one and three months after the intervention.

Based on previous studies, using 5A’s model in weight loss counseling resulted in successful lifestyle modification in different groups2628. In 5A’s model, the counselor focuses on the client's knowledge of his or her circumstances and behaviors. In this model, the client is actively involved in designing his/her lifestyle modification program and agrees with the counselor on behavioral goals28. In addition, during the following steps, with the help of a counselor, planning is done to improve the lifestyle.

The positive effect of client participation in nutrition counseling for chronic patients has been previously reported on counselor-client relationships31, and this approach has been accepted as a critical part of evidence-based practice32. Moreover, based on the results of a study, it is necessary to include unique psychological considerations of the disease in the behavioral interventions for the lifestyle of women with PCOS to encourage them to participate in such studies10.

The clients' participation in the 5A’s-based counseling program provides an opportunity for them to plan for lifestyle modification based on their specific psychological conditions and limitations and not to become anxious after receiving lifestyle modification counseling. It was confirmed by another research finding indicating an increase in psychological symptoms in the control group.

These results suggest that although lifestyle counseling for the modification of dietary behaviors and physical activity without considering the psychological condition of PCOS patients may lead to lifestyle improvements, it increases psychological symptoms as well. These results are in line with Hassan et al., who reported that anxiety and depression disorders were related to an unhealthy lifestyle in women with PCOS33.

These results show that women with PCOS need nutritional advice, physical activity, psychological support, and increased self-efficacy to control the condition. According to Lin et al., most women who were aware of the complications of PCOS believed that some critical complications of the disease could not be controlled by diet modification and physical activity34. However, during 5A’s model, the counselor is provided with an opportunity to correct the misconceptions by identifying these factors. Thus, this research confirmed that using these opportunities can improve the mental health of the participants with PCOS. Assessing experiences in women with PCOS has shown that these women need to be psychologically supported to modify their lifestyle35. According to another study, implementing supportive programs has effectively empowered women with PCOS to manage their lifestyle36.

The client's participation in developing a lifestyle modification program during multiple stages of designing a counseling model based on 5A’s model is another feature of this model. Using this model, the client gains the necessary knowledge not only about the disease and the impact of behavior change programs but also about planning for lifestyle modification. The client’s participation in planning can lead to self-confidence in controlling the situation32,35. Additionally, the patient’s perception of the controllability of the disease can be associated with disease acceptance14 and subsequent mental health promotion.

According to another study finding, unlike the intervention group, the level of obsessive–compulsive disorder in the control group increased during the study.

This finding shows that using this model is not associated with decreased obsessive–compulsive disorders; however, the increase in this symptom in the control group in the one- and three-month follow-up indicates that counseling can prevent the increase in obsessive–compulsive disorder in the recipients of lifestyle modification counseling.

The high risk of obsessive–compulsive disorder in women with PCOS has been reported in previous studies37. The present study showed that lifestyle modification counseling in women with PCOS without considering their psychological condition might increase their psychological symptoms.

The present study did not evaluate changes in lifestyle-related behaviors. The results, thus, have to be interpreted by considering this limitation because the difference in following the recommendations of lifestyle modification in the two groups may be related to psychological changes, which could not be examined in this study and is recommended to be considered in future studies. Moreover, due to the financial limitations of the research project, the effect of the intervention on the women's mental health was only followed up to three months, which was another limitation of the study.

This study has provided a client-centered model for lifestyle modification counseling in women with PCOS, which can also moderate their psychological burden. The results indicated that using 5A’s model for lifestyle modification counseling can lead to positive outcomes concerning the psychological health of women. Therefore, this model is recommended for providing lifestyle modification counseling programs in infertility centers and centers providing health services.

Acknowledgements

The authors gratefully acknowledge the Institutional Review Board affiliated with Isfahan University of Medical Sciences that supported financially this research project.

Author contributions

F.Z. wrote the main manuscript text. A.K. involved in data collection supervising, acquisition of analysis, interpretation of data, and editing the manuscript. Z.F. and M.S. involved in designing the intervention, interpretation of data, and editing the manuscript. All authors reviewed the manuscript.

Funding

This study was funded by Isfahan University of Medical Sciences (Grant number: 395508).

Data availability

Data and material are available on request from the corresponding author.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Alur-Gupta S, Chemerinski A, Liu C, Lipson J, Allison K, Sammel MD, et al. Body image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety. Fertil. Steril. 2019;112(5):930–938. doi: 10.1016/j.fertnstert.2019.06.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Tay CT, Teede HJ, Hill B, Loxton D, Joham AE. Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: A community-based cohort study. Fertil. Steril. 2019;112(2):353–361. doi: 10.1016/j.fertnstert.2019.03.027. [DOI] [PubMed] [Google Scholar]
  • 3.Glowinska A, Duleba AJ, Zielona-Jenek M, Siakowska M, Pawelczyk L, Banaszewska B. disparate relationship of sexual satisfaction, self-esteem, anxiety, and depression with endocrine profiles of women with or without PCOS. Reprod. Sci. 2020;27(1):432–442. doi: 10.1007/s43032-019-00061-0. [DOI] [PubMed] [Google Scholar]
  • 4.Yin XC, Ji YN, Chan CLW, Chan CHY. The mental health of women with polycystic ovary syndrome: A systematic review and meta-analysis. Arch. Womens Ment. Health. 2021;24(1):11–27. doi: 10.1007/s00737-020-01043-x. [DOI] [PubMed] [Google Scholar]
  • 5.Rimmer M, Tan BK, Teede H, Thangaratinam S, Al Wattar BH. Metabolic inflexibility in women with polycystic ovary syndrome: A systematic review. Gynecol. Endocrinol. 2020;36:501–507. doi: 10.1080/09513590.2019.1698025. [DOI] [PubMed] [Google Scholar]
  • 6.Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C. Cardiovascular risk in women with polycystic ovary syndrome. J. Cardiovasc. Med. 2008;9(10):987–992. doi: 10.2459/JCM.0b013e32830b58d4. [DOI] [PubMed] [Google Scholar]
  • 7.Weiss J, Kupker W. Obesity, polycystic ovary syndrome, cancer. Gynakol. Endokrinol. 2017;15(2):116–120. doi: 10.1007/s10304-017-0133-3. [DOI] [Google Scholar]
  • 8.Naz MSG, Tehrani FR, Ozgoli G. Polycystic ovary syndrome in adolescents: a qualitative study. Psychol. Res. Behav. Manag. 2019;12:715–723. doi: 10.2147/PRBM.S207727.eCollection. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Pena AS, Witchel SF, Hoeger KM, Oberfield SE, Vogiatzi MG, Misso M, Garad R, Dabadghao P, Teede H. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 2020;18(1):1. doi: 10.1186/s12916-020-01516-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. 2018;33(9):1602–1618. doi: 10.1093/humrep/dey256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Porchia LM, Hernandez-Garcia SC, Gonzalez-Mejia ME, Lopez-Bayghen E. Diets with lower carbohydrate concentrations improve insulin sensitivity in women with polycystic ovary syndrome: A meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Bio. 2020;248:110–117. doi: 10.1016/j.ejogrb.2020.03.010. [DOI] [PubMed] [Google Scholar]
  • 12.Patel V, Menezes H, Menezes C, Bouwer S, Bostick-Smith CA, Speelman DL. Regular mindful yoga practice as a method to improve androgen levels in women with polycystic ovary syndrome: A randomized controlled trial. J. Am. Osteopath. Asso. 2020;120(5):323–335. doi: 10.7556/jaoa.2020.050. [DOI] [PubMed] [Google Scholar]
  • 13.Munt AE, Partridge SR, Allman-Farinelli M. The barriers and enablers of healthy eating among young adults: A missing piece of the obesity puzzle: A scoping review. Obesity Rev. 2017;18(1):1–17. doi: 10.1111/obr.12472. [DOI] [PubMed] [Google Scholar]
  • 14.Rzonca E, Iwanowicz-Palus G, Bien A, Wdowiak A, Szymanski R, Cholubek G. Generalized self-efficacy, dispositional optimism, and illness acceptance in women with polycystic ovary syndrome. Int. J. Environ. Res. Public Health. 2018;15(11):10. doi: 10.3390/ijerph15112484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Harwood K, Vuguin P, DiMartino-Nardi J. Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth. Horm. Res. 2007;68:209–217. doi: 10.1159/000101538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Wright PJ, Dawson RM, Corbett CF. Social construction of biopsychosocial and medical experiences of women with polycystic ovary syndrome. J. Adv. Nurs. 2020;76(7):1728–1736. doi: 10.1111/jan.14371. [DOI] [PubMed] [Google Scholar]
  • 17.Scaruffi E, Franzoi IG, Civilotti C, Guglielmucci F, La Marca L, Tomelini M, Veglia F, Granieri A. Body image, personality profiles and alexithymia in patients with polycystic ovary syndrome (PCOS) J. Psychosom. Obst. Gyn. 2019;40(4):294–303. doi: 10.1080/0167482X.2018.1530210. [DOI] [PubMed] [Google Scholar]
  • 18.Weiss TR, Bulmer SM. Young women's experiences living with polycystic ovary syndrome. Jognn J. Obst. Gyn. Neo. 2011;40(6):709–718. doi: 10.1111/j.1552-6909.2011.01299.x. [DOI] [PubMed] [Google Scholar]
  • 19.Ekramzadeh M, Hajivandi L, Noroozi M, Mostafavi F. Psychological experiences of adolescent girls with polycystic ovary syndrome: A qualitative study. Iran. J. Nurs. Midwifery Res. 2020;25(4):341–347. doi: 10.4103/ijnmr.IJNMR_276_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Mani H, Chudasama Y, Hadjiconstantinou M, Bodicoat DH, Edwardson C, Levy MJ, et al. Structured education programme for women with polycystic ovary syndrome: A randomised controlled trial. Endocr. Connect. 2018;7(1):26–35. doi: 10.1530/EC-17-0274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rocha AL, Oliveira FR, Azevedo RC, Silva VA, Peres TM, Candido AL, et al. Recent advances in the understanding and management of polycystic ovary syndrome. Research. 2019 doi: 10.12688/f1000research.15318.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kazemi M, Pierson RA, McBreairty LE, Chilibeck PD, Zello GA, Chizen DR. A randomized controlled trial of a lifestyle intervention with longitudinal follow-up on ovarian dysmorphology in women with polycystic ovary syndrome. Clin. Endocrinol. 2020;92(6):525–535. doi: 10.1111/cen.14179. [DOI] [PubMed] [Google Scholar]
  • 23.Carolo AL, Mendes MC, Rosa ESA, Vieira CS, Silva de Sá MF, Ferriani RA, et al. Nutritional counseling promotes changes in the dietary habits of overweight and obese adolescents with polycystic ovary syndrome. Rev. Bras. Ginecol. Obstet. 2017;39(12):692–696. doi: 10.1055/s-0037-1607458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Cooney LG, Milman LW, Hantsoo L, Kornfield S, Sammel MD, Allison KC, et al. Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: A pilot randomized clinical trial. Fertil. Steril. 2018;110(1):161. doi: 10.1016/j.fertnstert.2018.03.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ko H, Teede H, Moran L. Analysis of the barriers and enablers to implementing lifestyle management practices for women with PCOS in Singapore. BMC. Res. Notes. 2016;9:311. doi: 10.1186/s13104-016-2107-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Fitzpatrick SL, Wischenka D, Appelhans BM, Pbert L, Wang M, Wilson DK, Pagoto SL. An evidence-based guide for obesity treatment in primary care. Am. J. M. Sc. 2016;129(1):115.e1–115.e7. doi: 10.1016/j.amjmed.2015.07.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Asselin J, Salami E, Osunlana AM, Ogunleye AA, Cave A, Johnson JA, Sharma AM, Campbell-Scherer DL. Impact of the 5As team study on clinical practice in primary care obesity management: A qualitative study. CMAJ. 2017;5(2):E322–E329. doi: 10.9778/cmajo.20160090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mateo KF, Berner NB, Ricci NL, Seekaew P, Sikerwar S, Tenner C, Dognin J, Sherman SE, Kalet A, Jay M. Development of a 5As-based technology-assisted weight management intervention for veterans in primary care. BMC Health Serv. Res. 2018;18(1):47. doi: 10.1186/s12913-018-2834-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil. Steril. 2016;106(1):6–15. doi: 10.1016/j.fertnstert.2016.05.003. [DOI] [PubMed] [Google Scholar]
  • 30.Martinez-Pampliega A, Herrero-Fernandez D, Martin S, Cormenzana S. Psychometrics of the SCL-90-R and development and testing of brief versions SCL-45 and SCL-9 in infertile couples. Nurs. Res. 2019;68(4):E1–E10. doi: 10.1097/NNR.0000000000000363. [DOI] [PubMed] [Google Scholar]
  • 31.Jakobsen NS, Kaufmann L, Hennesser Y, Kristensen ST. A new approach for the dietitian that strengthens the relationship and collaboration with clients. Top. Clin. Nutr. 2017;32(3):229–242. doi: 10.1097/TIN.0000000000000111. [DOI] [Google Scholar]
  • 32.Drisko J, J. Active collaboration with clients: An underemphasized but vital part of evidence-based practice. Soc. Work. 2017;62(2):114–121. doi: 10.1093/sw/swx003. [DOI] [PubMed] [Google Scholar]
  • 33.Hasan M, Sultana S, Sohan M, Parvin S, Rahman MA, Hossain MJ, Rahman MS, Islam MR. Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross-sectional study. PLoS ONE. 2022;17(6):e0270102. doi: 10.1371/journal.pone.0270102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lin AW, Dollahite JS, Sobal J, Lujan ME. Health-related knowledge, beliefs and self-efficacy in women with polycystic ovary syndrome. Hum. Reprod. 2018;33(1):91–100. doi: 10.1093/humrep/dex351. [DOI] [PubMed] [Google Scholar]
  • 35.Brennan L, Teede H, Skouteris H, Linardon J, Hill B, Moran L. Lifestyle and behavioral management of polycystic ovary syndrome. J. Women's Health. 2017;26(8):836–848. doi: 10.1089/jwh.2016.5792. [DOI] [PubMed] [Google Scholar]
  • 36.Kozica SL, Gibson-Helm ME, Teede HJ, Moran LJ. Assessing self-efficacy and self-help methods in women with and without polycystic ovary syndrome. Ann. Behav. Med. 2013;39(3):90–96. doi: 10.1080/08964289.2012.720312. [DOI] [PubMed] [Google Scholar]
  • 37.Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, Glowinska A, Spaczynski R, Rybakowski F, Pawelczyk L, Banaszewska B. Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr. Pol. 2019;53(4):955–966. doi: 10.12740/PP/OnlineFirst/93105. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data and material are available on request from the corresponding author.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES